SIH Partners, L »

Summit Therapeutics shares owned by SIH Partners, L

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by SIH Partners, L from 13F filings

Historical chart of SIH Partners, L investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by SIH Partners, L consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by SIH Partners, L

Quarter filed Position value Share count Share price at filing
2025-03-31 $897k 47k 19.29

More positions owned by SIH Partners, L

Stellantis SHS (STLA)
Ubs Group SHS (UBS)
Alcon Ord Shs (ALC)
Deutsche Bank A G Namen Akt (DB)
Ferrari Nv Ord (RACE)
Logitech Intl S A SHS (LOGI)
Bhp Group Sponsored Ads (BHP)
Jd.com Spon Ads Cl A (JD)
Ferrovial Se Ord Shs (FER)
Netease Sponsored Ads (NTES)
Alibaba Group Hldg Sponsored Ads (BABA)
Dbx Etf Tr Xtrack Hrvst Csi (ASHR)
Apple (AAPL)
Amrize SHS (AMRZ)
Bitmine Immersion Tecnologie Com New (BMNR)

View all positions for SIH Partners, L

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
Susquehanna International
Pictet Asset Management Holding SA
Citadel Advisors
UBS Group
Apeiron Capital
Nomura Holdings
Standard Life Aberdeen
Squarepoint Ops
Sofinnova Ventures

View all funds holding Summit Therapeutics